Effect of Altitude on Iron Absorption in Iron Depleted Women
NCT05500014 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2024-04-17
Summary
One of the most common nutritional deficiencies worldwide is iron deficiency. Iron deficiency is considered the main cause of anaemia in developing countries, including those in South America. The most recent surveys report that the prevalence of anaemia is as high as, 40 and 25% in Peru.
Populations living at higher altitudes may have higher iron requirements, as body iron is naturally increased in long-term high-altitude residents to compensate for the lower oxygen in the air at high altitudes. However, the effects of chronic exposure to high altitude on iron status, body iron compartments and dietary iron requirements are incompletely understood.
The primary objective of the proposed research is to determine iron bioavailability of iron from biofortified potatoes at different altitudes in populations of Andean descent. Human trials will be undertaken with volunteers in the Huancavelica region of Peru (elevation: 3676 meters) as well as in Lima (elevation close to sea level). The aim is to assess the effect of altitude on the absorption from a promising iron biofortified potato cultivar. These trials require incorporation of iron stable isotopes into the meals of the bio fortified potato and the analysis of the isotopes in subsequent blood (red blood cells) samples. Stable iron istotopes are considered the golden standard to assess human iron absorption and can be safely used as tracer substances in humans.
The objective of the study is to compare, in volunteer females of childbearing age, the bioavailability of iron from bio-fortified potatoes in two locations of different altitudes and quantify the effect of altitude on iron bioavailability from a potato meal consumed over 5 consecutive days.
Conditions
- Iron Deficiency Anemia
- Iron Deficiency (Without Anemia)
- Altitude Hypoxia
Interventions
- OTHER
-
Biofortified potato, not genetically modified
Cooked potato, not genetically modified, with the addition of an acqueous solution of 57FeSO4 (3 mg in total).
Sponsors & Collaborators
-
ETH Zurich (Switzerland)
collaborator OTHER -
Instituto de Investigacion Nutricional, Peru
collaborator OTHER -
Swiss Distance University of Applied Sciences
lead OTHER
Principal Investigators
-
Diego Moretti, PhD · Swiss Distance University of Applied Sciences
-
Maria-Reyna Liria, PhD · Insituto Investigation Nutritional
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-08-20
- Primary Completion
- 2023-02-01
- Completion
- 2024-04-30
Countries
- Peru
Study Locations
More Related Trials
-
Effect Of Intravenous Iron Versus Placebo On Muscle Oxidative Capacity And Physical Performance in Premenopausal Women
NCT01374776 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Cobalt's Role in Excessive Erythrocytosis Among High Altitude Dwellers in Cerro de Pasco, Peru
NCT01187108 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Hospitalization & Mortality in Patients With Iron Deficiency CKD and HF Treated With i.v. Iron.
NCT02392910 ·Status: COMPLETED ·Phase: PHASE4
-
Causes and Mechanisms of Space Hemolysis At High Altitudes
NCT05496309 ·Status: COMPLETED
-
Effectiveness of Low-dose Iron Treatment in Non-anaemic Iron-deficient Women
NCT04636060 ·Status: COMPLETED ·Phase: NA
-
Relative Contributions of Red Cell Catabolism and Dietary Absorption to Fetal Iron Accretion During Pregnancy
NCT01588665 ·Status: COMPLETED
-
Alternate Day vs. Daily Iron Supplementation in Iron Depleted Women
NCT05105438 ·Status: COMPLETED ·Phase: NA
-
The Impact of Red Packed Cells Transfusion on the Main Biological Markers to Determine the Etiology of Anemias
NCT01409967 ·Status: COMPLETED
-
Incidence of Iron Deficiency in Polycythemia Vera (PV) and Association With Disease Features
NCT02809274 ·Status: UNKNOWN
-
Oxidative Stress and Iron Overload in Patient With Abnormal Haemoglobinopathy
NCT05586932 ·Status: UNKNOWN
-
Effect of IV Iron in Patients With Heart Failure With Preserved Ejection Fraction
NCT03074591 ·Status: COMPLETED ·Phase: PHASE4
-
Oral Iron Supplementation in Pulmonary Hypertension
NCT01446848 ·Status: COMPLETED ·Phase: NA
-
Iron Therapy in Erythropoietic Protoporphyria
NCT05572125 ·Status: COMPLETED
-
Absorption of Heme and Non-Heme Iron in Pregnant and Non-pregnant Women and Mechanisms of Fetal Iron Transfer
NCT01019096 ·Status: COMPLETED
-
Ferritin Screening And IRon Treatment for Maternal Anemia and FGR Prevention Trial
NCT04228627 ·Status: COMPLETED ·Phase: PHASE4
-
Hibiscus Sabdariffa and Centella Asiatica in the Treatment of Anemia by Iron Deficiency
NCT01414374 ·Status: COMPLETED ·Phase: PHASE3
-
Using Stable Iron Isotopic Techniques and Serum Hepcidin Profiles to Optimize Iron Supplementation
NCT01785407 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (< 500 ng/ml)
NCT01996683 ·Status: UNKNOWN ·Phase: NA
-
"Iron Overload and Endocrinological Diseases"
NCT06137079 ·Status: RECRUITING
-
IRON DEFICIENCY ANEMIA IN RELATION TO PINCH STRENGTH AND HAND DEXTERITY IN PRESCHOOL CHILDREN
NCT05959122 ·Status: COMPLETED
-
Measurements of Body Iron Excretion of Healthy Adults
NCT00755105 ·Status: COMPLETED
-
Clinical and Laboratory Investigation of Humans With Informative Iron or Erythroid Phenotypes
NCT00102245 ·Status: TERMINATED
-
Iron Status in BTM With Blood Transfusion
NCT04947540 ·Status: UNKNOWN
-
Malabsorption as a Cause of Iron Treatment Failure in Infants
NCT00456729 ·Status: COMPLETED ·Phase: NA
-
Iron Interventions and Non-transferrin-bound Iron (NTBI) in Women
NCT01404533 ·Status: COMPLETED ·Phase: NA